相关实验视频
Updated: Jul 3, 2025

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
1.6K
由免疫检查点抑制剂诱导的甲状腺疾病
Dimitra Karaviti1, Eleni-Rafaela Kani1, Eleftheria Karaviti1
1Endocrine Unit and Diabetes Center, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Endocrine
|February 12, 2024
概括
免疫检查点抑制剂 (ICI) 可以导致甲状腺功能障碍作为副作用. 本综述涵盖了ICI诱导的甲状腺问题的模式,诊断和管理,以改善患者的护理.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 免疫检查点抑制剂 (ICI) 是利用免疫系统的重要癌症疗法.
- 与免疫相关的不良反应 (irAEs),特别是内分泌病变,在ICI使用中很常见.
- 甲状腺功能障碍是与ICI治疗相关的常见内分泌病.
研究的目的:
- 审查ICI诱导的甲状腺功能障碍的重要性.
- 探索它的模式,机制,诊断和治疗.
- 突出影响功能障碍风险的因素.
主要方法:
- 关于ICI诱导的甲状腺功能障碍的文献综述.
- 分析病理生理机制,包括破坏性甲状腺炎.
- 诊断和治疗策略的总结.
主要成果:
- 甲状腺功能障碍表现为甲状腺毒性,甲状腺功能低下或两者兼而有之.
- 诊断包括临床,实验室和成像评估.
- 治疗方法有所不同,从勒沃西替代剂到β抑制剂.
结论:
- 有效地识别和管理ICI诱导的甲状腺功能障碍对于患者的安全和结果至关重要.
- 了解影响因素,如癌症类型和ICI剂量是很重要的.
- 本综述为临床医生管理这些并发症提供了全面的指南.
相关概念视频
Autoimmune Disorders
436
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
436
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Synthesis and Regulation of Thyroid Hormones
4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
164
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
164
Immunodeficiency Diseases
939
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
939
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K

